Drug
Vortioxetine Single Dose
Vortioxetine Single Dose: highest development phase Phase 1, developed by Lundbeck. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Lundbeck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Vortioxetine 10 mg single dose NCT02386488 | Phase 1 | Pharmacokinetics |
Latest
No recent events.
Follow Vortioxetine Single Dose on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.